Compass Points™

Improving Communication in the Management of Parkinson's Disease

by Christina J. Ansted, MPH, CCMEP

There are currently at least 1 million people in the United States who are affected by Parkinson's disease (PD), and effective provider-patient communication is a critical aspect of disease management for these patients. However, effective provider-patient communication remains an unmet need in the management of PD...

> Read more (Earn up to 0.5 AMA PRA Category 1 Credit(s)™)
> Back to top

Responses from Last
Compass Questions™

In the 02.21.12 issue of Clinical Compass™, we asked four questions.

Question #1 was "Before reading this article, state how aware you were of recent events and study data related to the risks of excessive sleepiness on occupational and public safety:" and the neuroscienceCME learning community responded:
12.7% - Extremely aware
30.6% - Very aware
45.2% - Somewhat aware
7.6% - Not very aware
3.9% - Not at all aware

Question #2 was "Now that you have read this article, how aware are you of recent events and study data related to the risks of excessive sleepiness on occupational and public safety?" and the neuroscienceCME learning community responded:
33.3% - Extremely aware
49.4% - Very aware
13.7% - Somewhat aware
3.6% - Not very aware
0.0% - Not at all aware

Question #3 was "Before reading this article, state how often you shared data from studies when you counsel patients on occupational and public safety risks associated with excessive sleepiness:" and the neuroscienceCME learning community responded:
7.0% - Always
23.1% - Often
29.5% - Sometimes
25.0% - Rarely
15.4% - Never

Question #4 was "Now that you have read this article, how often do you plan to share data from studies when you counsel patients on occupational and public safety risks associated with excessive sleepiness?" and the neuroscienceCME learning community responded:
39.7% - Always
43.0% - Often
15.2% - Sometimes
1.3% - Rarely
0.8% - Never

> Back to top

neuroscienceCME Live and On Demand

Implementing Informed Treatment Options in Antipsychotic Therapy

Premiere Date: Wednesday, April 4, 2012
Live Broadcast: 12:00–1:30 p.m. ET
Taped Re-Air: 4:00–5:30 p.m. ET

This neuroscienceCME Live and On Demand activity reviews the array of pharmacologic and non-pharmacologic treatment options for patients with schizophrenia, as well as other issues such as adverse events and metabolic issues. Faculty will provide a thorough review of currently-approved antipsychotic agents and their pharmacologic mechanisms and side effects, and review family involvement, psychoeducation and other components of individualized, multimodal treatment strategies.

> View activity details
> Add to calendar

> Back to top

REGISTER NOW FOR EARLY BIRD PRICING! 5th Annual Chair Summit - Master Class for Neuroscience Professional Development

Symposium Dates: October 11-13, 2012
Location: Gaylord Palms Hotel
6000 W Osceola Parkway, Orlando, FL 34746
407.586.2000 (Group Code: CME Outfitters)

The 5th Annual Chair Summit offers in-depth and interactive learning opportunities, all led by renowned experts in the neurosciences. In just two and a half days, and at a fraction of the cost of larger conferences, get direct answers to all your clinical questions, engage with your peers, and enhance your care of patients who suffer with psychiatric and neurologic disorders.

> View activity details
> Add to calendar

> Back to top

Participate in a Mobile Survey

Which device do you use most offen as part of your daily communication, clinical work, social, educational or recreational activites?